Medical Journal

Elsevier sends wave of takedown requests

Elsevier sends wave of takedown requests

By

Elsevier is taking a hard-line posture against several different universities, asking them to take down scholarly research.

Japan investigates cancer "articles"

The Heath, Labor and Welfare ministry says a publisher passed off advertorials as articles.

Study reveals doc detail preferences: Hang up the phone

Study reveals doc detail preferences: Hang up the phone

By

Doctors shared their information preferences with CMI/Compas, revealing ways marketers can better pace their communications to max out channels.

Print: Still not dead

By

Studies show that printed pieces still hold sway in the industry.

BMJ will require authors to disclose clinical trial data

By

Starting next year, the BMJ will not publish academic papers on drugs or devices unless the relevant anonymized patient-level data are made available for third-party study.

JAMA taps NEJM's Easley as publisher

JAMA taps NEJM's Easley as publisher

By

The American Medical Association has wooed New England Journal of Medicine publisher Tom Easley to Chicago, where he will preside over the society's publications, soon to be rolled up into the JAMA brand.

Study finds false data top reason for journal retractions

By

A study found fraud rampant in retracted journal articles -- and publishers less than transparent about why articles were pulled

Quadrant buys IMNG, becoming biggest medical publisher by ad revenue

Quadrant buys IMNG, becoming biggest medical publisher by ad revenue

By

Privately owned Quadrant HealthCom acquired International Medical News Group (IMNG) from Elsevier, creating a new medical-publishing juggernaut.

New ad model fosters pharma's leap to digital, publisher finds

New ad model fosters pharma's leap to digital, publisher finds

By

Statistics show medical professionals are migrating toward iPads. Now, one medical journal publisher says, advertisers have followed.

Roundtable outlines path for publisher, pharma credibility

By

In an effort to shore up their reputations, pharma and professional publishers have come together to craft an accountability plan.

JAMA feature aims to spark debate and hits a nerve

JAMA feature aims to spark debate and hits a nerve

By

Journals are a curious media form in that they provide fodder for debate on medical topics, but not a forum in which to hold one. Enter JAMA's new Viewpoint feature.

Harvard urges faculty to ditch journals

Harvard urges faculty to ditch journals

By

An email from Harvard University's Faculty Advisory Council over the cost of professional journals has touched off the latest round in the Universities vs Publishers sparring match.

Journal "pharmascolds" skew policy, says study

By

Medical journal coverage of the question of physician-industry relationships is "unbalanced" and may be skewing public policy towards ever-more restrictive safeguards against industry influence.

Company news: Publicis and the American Heart Association

Publicis Groupe is expanding its footprint in China, having acquired the healthcare communications agency U-Link Solutions Co. Ltd.

MAHF inducts MedEc's Daly, Sudler's Smith and LLNS' Nickel

MAHF inducts MedEc's Daly, Sudler's Smith and LLNS' Nickel

By

The Medical Advertising Hall of Fame announced its 2012 inductees: Medical Economics' Charles Daly, Sudler & Hennessey creative great Ernest Smith and LLNS co-founder Al Nickel.

Despite decline, ghostwriting in papers still common: study

By

Researchers analyzing the prevalence of ghostwriting in leading medical journals over more than a decade saw a decline but found inappropriate authorship remained all too common.

Majority of pharma journal ads not FDA-compliant: study

By

Four out of five ads analyzed in a study of physician-directed pharmaceutical advertising would definitely not pass FDA muster, or might have trouble doing so, said researchers. Their findings may have implications for the FDA, DDMAC and the "Bad Ad" program.

New cancer journal tackles advances in research

By

The American Association for Cancer Research will launch a new journal -- Cancer Discovery -- in April 2011. The peer-reviewed journal will focus on research spanning cancer science and medicine, including news, commentaries, and "Research Watch" summaries of important journal articles.

Two-for-one: Quadrant pairs journal titles for advertisers

Two-for-one: Quadrant pairs journal titles for advertisers

By

Quadrant HealthCom united two titles - The Female Patient and OBG Management - under an alliance providing advertisers with a "ping-pong" opportunity for campaigns.

SequenceDoc portal to deliver custom journals for docs

By

Custom media provider Sequence Personal, and CMI, have partnered to create SequenceDoc, a portal for physicians offering tailored medical content served up as an on-demand print journal, or as a digital download.

Thieme to distribute Manson titles in the US

Thieme to distribute Manson titles in the US

By

Thieme Publishers will distribute UK-based Manson Publishing titles in the Americas and India, a portfolio that includes close to 100 medical and veterinary titles.

NEJM revamps website, adds complete archive

NEJM revamps website, adds complete archive

By

The New England Journal of Medicine launched a new website on July 24, including an archive of past issues dating back to 1812. Over 150,000 articles are now available for digital searching and perusal.

Sage upgrades online journal platform

Sage upgrades online journal platform

By

Sage, an international publisher of medical journals, books and electronic media, is shifting all of its 560-plus titles onto a new platform hosted by Stanford University Libraries' HighWire Press.

Specialty societies' code targets conflicts of interest

By

Medical society journals must ban ghostwritten articles and cannot place ads for drugs next to editorial content discussing those products or their makers under a sweeping ethics code signed by several major medical societies.

New journal devoted to hot button issue: childhood obesity

New journal devoted to hot button issue: childhood obesity

By

First Lady Michelle Obama's recent announcement of a campaign to end childhood obesity was not lost on medical publisher Mary Ann Liebert, Inc., which will roll out a new journal, Childhood Obesity, in June 2010.

AAFP pact with Coke distasteful to some

AAFP pact with Coke distasteful to some

By

An alliance with the nation's largest soft drink maker to sponsor advice on sugar-free alternatives has spurred criticism of the American Academy of Family Physicians (AAFP).

Journal editors subject authors to greater scrutiny

By

Researchers submitting manuscripts to many medical journals will have to fill out a more probing disclosure form aimed at exposing potential conflicts of interest.

"Facebook for pharmacists" to offer news, CE and community

"Facebook for pharmacists" to offer news, CE and community

By

JMI Health is launching PharmQD, which aims to be something like a cross between LinkedIn and Facebook for pharmacy students, hospital and retail pharmacists, said JMI SVP, eproducts Tina Pang Mayer (pictured).

Last chance to grab glory

Last chance to grab glory

If you still haven't entered the MM&M Awards 2009, then you'd better move fast--today (June 5) is the final deadline for submissions.

AMA ethics group rethinks CME funding

By

A pair of American Medical Association committee reports urges that industry-funded CME be put on a tighter leash, but they're a far cry from the ban on commercial support called for by the AMA's Council on Ethical and Judicial Affairs a year ago.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.